BRPI0410710A - composições e métodos que compreendem compostos de gastrina e seus usos - Google Patents

composições e métodos que compreendem compostos de gastrina e seus usos

Info

Publication number
BRPI0410710A
BRPI0410710A BRPI0410710-1A BRPI0410710A BRPI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A
Authority
BR
Brazil
Prior art keywords
compositions
methods
gastrin compounds
compounds
beneficial effects
Prior art date
Application number
BRPI0410710-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of BRPI0410710A publication Critical patent/BRPI0410710A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2207Gastrins; Cholecystokinins [CCK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0410710-1A 2003-05-27 2004-05-27 composições e métodos que compreendem compostos de gastrina e seus usos BRPI0410710A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (1)

Publication Number Publication Date
BRPI0410710A true BRPI0410710A (pt) 2006-06-13

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410710-1A BRPI0410710A (pt) 2003-05-27 2004-05-27 composições e métodos que compreendem compostos de gastrina e seus usos

Country Status (11)

Country Link
EP (1) EP1648495A2 (enExample)
JP (1) JP2007513059A (enExample)
CN (1) CN1829528A (enExample)
AU (1) AU2004243541A1 (enExample)
BR (1) BRPI0410710A (enExample)
CA (1) CA2527186A1 (enExample)
MX (1) MXPA05012605A (enExample)
NO (1) NO20055582L (enExample)
PL (1) PL379145A1 (enExample)
RU (1) RU2005140518A (enExample)
WO (1) WO2004105780A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1351742B1 (en) 2001-01-12 2008-10-15 Waratah Pharmaceuticals Inc. Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
ES2334268T3 (es) 2002-06-07 2010-03-08 Waratah Pharmaceuticals, Inc. Procedimientos y composiciones para el tratamiento de la diabetes.
AU2005207870B2 (en) * 2004-01-30 2010-08-19 Waratah Pharmaceuticals, Inc. The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
CA2182034C (en) * 1994-01-24 2009-04-21 Ronald V. Nardi Treatment for juvenile diabetes
EP1351742B1 (en) * 2001-01-12 2008-10-15 Waratah Pharmaceuticals Inc. Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
PL376473A1 (en) * 2002-10-22 2005-12-27 Waratah Pharmaceuticals, Inc. Treatment of diabetes

Also Published As

Publication number Publication date
NO20055582L (no) 2006-02-27
PL379145A1 (pl) 2006-07-24
WO2004105780A2 (en) 2004-12-09
MXPA05012605A (es) 2006-02-22
NO20055582D0 (no) 2005-11-25
CN1829528A (zh) 2006-09-06
JP2007513059A (ja) 2007-05-24
WO2004105780A3 (en) 2005-01-20
AU2004243541A1 (en) 2004-12-09
CA2527186A1 (en) 2004-12-09
RU2005140518A (ru) 2007-07-10
EP1648495A2 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
SE0001899D0 (sv) New compounds
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
BRPI0411862A (pt) combinações de substáncias ativas com propriedades inseticidas e acaricidas
BR0311222A (pt) R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
CR20150097A (es) Composición inmunogénica
BRPI0407139A (pt) Compostos de amida substituìda por tri(ciclo)
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
BRPI0515316A (pt) compostos de imidazoquinolina
BR0312232A (pt) Inibidores de caspases e seus usos
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
BRPI0517846A (pt) azaindolcarboxamidas
ATE516339T1 (de) Verwendung von isomeren von bicycloä2.2.1ühept-5- en-2-carbonsäure, ethylester in parfumzusammensetzungen, sowie parfumzusammensetzungen
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
BRPI0412862A (pt) derivados da nicotinamida úteis como inibidores de pde4
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
BRPI0410710A (pt) composições e métodos que compreendem compostos de gastrina e seus usos
BR0208131A (pt) Derivados biguanida
SE0004101D0 (sv) New use
UY29012A1 (es) "oxazolididonas y composiciones y metodos relacionados"
ATE373699T1 (de) Parfümierende bestandteile des holzigen typs
BRPI0519819A2 (pt) composição aquosa de amaciamento de tecidos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.